Conclusion This podcast episode offers a rich exploration of various health topics, providing valuable insights into GLP-1 medications, thyroid health, and hormone therapy
The Bests Company Report(s) reproduced on this site appear under license from A.M
GLP-1 receptor agonists work by reducing appetite, increasing satiety, and slowing gastric emptying, which affects how quickly food leaves your stomach
Durvi or Dr
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
Theyre looking for less, she said